1. Curcumin Induces Apoptosis of Colorectal Cancer Stem Cells by Coupling with CD44 Marker
   Yu-Ting Huang et al, 2016, J. Agric. Food Chem. CrossRef
2. Expression status of CD44 and CD133 as a prognostic marker in esophageal squamous cell carcinoma treated with neoadjuvant chemotherapy followed by radical esophagectomy
   Koichi Okamoto et al, 2016 CrossRef
3. LGR5, a relevant marker of cancer stem cells, indicates a poor prognosis in colorectal cancer patients: A meta-analysis
   Ye Han et al, 2015, Clinics and Research in Hepatology and Gastroenterology CrossRef
4. Combination antitumor therapy with targeted dual-nanomedicines
   Wenbing Dai et al, 2017, Advanced Drug Delivery Reviews CrossRef
5. Construction and Evaluation of a Targeted Hyaluronic Acid Nanoparticle/Photosensitizer Complex for Cancer Photodynamic Therapy
   Shi Gao et al, 2017, ACS Appl. Mater. Interfaces CrossRef
6. Long intergenic non-protein-coding RNA 1567 (LINC01567) acts as a “sponge” against microRNA-93 in regulating the proliferation and tumorigenesis of human colon cancer stem cells
   Xiaofeng Yu et al, 2017, BMC Cancer CrossRef
7. Green synthesis of hyaluronic acid-based silver nanoparticles and their enhanced delivery to CD44+ cancer cells
   Jianming Liang et al, 2015, RSC Adv. CrossRef
8. The expression of cancer stem cell markers in human colorectal carcinoma cells in a microenvironment dependent manner
   Vaidotas Stankevicius et al, 2017, Biochemical and Biophysical Research Communications CrossRef
9. Suppression of cancer stemness by upregulating Ligand-of-Numb protein X1 in colorectal carcinoma
   Lin Ma et al, 2017, PLoS ONE CrossRef
10. Self-renewal molecular mechanisms of colorectal cancer stem cells.
    Tianhui Pan et al, 2017, Int J Mol Med CrossRef
11. Sasa quelpaertensis Leaf Extract Inhibits Colon Cancer by Regulating Cancer Cell Stemness in Vitro and in Vivo
    Soo Min et al, 2015, IJMS CrossRef
12. Evodiamine, a Novel NOTCH3 Methylation Stimulator, Significantly Suppresses Lung Carcinogenesis in Vitro and in Vivo
    Tao Su et al, 2018, Front. Pharmacol. CrossRef
13. Effect of Cinnamic acid and FOLFOX in diminishing side population and downregulating cancer stem cell markers in colon cancer cell line HT-29
    Sara Soltanian et al, 2018, DARU J Pharm Sci CrossRef
14. Tumidulin, a Lichen Secondary Metabolite, Decreases the Stemness Potential of Colorectal Cancer Cells
    Yi Yang et al, 2018, Molecules CrossRef
15. Augmented CD133 expression in distal margin correlates with poor prognosis in colorectal cancer
    Tapas Pradhan et al, 2019, J Cell Mol Med CrossRef
16. New targets for the immunotherapy of colon cancer—does reactive disease hold the answer?
    V Boncheva et al, 2013, Cancer Gene Ther CrossRef
17. MicroRNAs regulate both epithelial-to-mesenchymal transition and cancer stem cells
    P Ceppi et al, 2014, Oncogene CrossRef
18. null
    Toshiyuki Matsunaga et al, 2013 CrossRef
19. null
    Jong Min Park et al, 2015 CrossRef
20. null
    Kaushik Kuche et al, 2019 CrossRef
21. An Fc-Optimized CD133 Antibody for Induction of Natural Killer Cell Reactivity against Colorectal Cancer
    null Schmied et al, 2019, Cancers CrossRef
22. Increased growth of colorectal liver metastasis following partial hepatectomy
    P. Krause et al, 2013, Clin Exp Metastasis CrossRef
23. Cancer stem cells: A review from origin to therapeutic implications.
    Mohammad Reza Atashzar et al, 2020, J Cell Physiol CrossRef
24. Genetic reconstitution of tumorigenesis in primary intestinal cells
    K. Onuma et al, 2013, Proceedings of the National Academy of Sciences CrossRef
25. null
    Mukesh Verma et al, 2019 CrossRef
26. CD44 as a molecular marker to screen cancer stem cells in hypopharyngeal cancer
    Chenling Shen et al, 2013, Acta Oto-Laryngologica CrossRef
27. TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cells.
    Jun Fu et al, 2013, Neuro Oncol CrossRef
28. Cancer stem cell gene profile as predictor of relapse in high risk stage II and stage III, radically resected colon cancer patients.
    Riccardo Giampieri et al, 2013, PLoS One CrossRef
29. Salinomycin exerts anti-colorectal cancer activity by targeting the β-catenin/T-cell factor complex.
    Zhongyuan Wang et al, 2019, Br J Pharmacol CrossRef
30. CD133 and CD133-regulated nucleophosmin linked to 5-fluorouracil susceptibility in human colon cancer cell line SW620
    Kyung-Hee Kim et al, 2014, ELECTROPHORESIS CrossRef
31. KIN enhances stem cell-like properties to promote chemoresistance in colorectal carcinoma
    Miao Yu et al, 2014, Biochemical and Biophysical Research Communications CrossRef
32. Establishment of Highly Tumorigenic Human Colorectal Cancer Cell Line (CR4) with Properties of Putative Cancer Stem Cells
    Rebecca A. Rowehl et al, 2014, PLoS ONE CrossRef
33. Chemoquiescence for Ideal Cancer Treatment and Prevention: Where Are We Now?
    Napapan Kangwan et al, 2014 CrossRef
34. PTK7 regulates Id1 expression in CD44-high glioma cells.
    Qing Liu et al, 2015, Neuro-oncology CrossRef
35. The Cancer Stem Cell Hypothesis: A Guide to Potential Molecular Targets
    Alessandro Allegra et al, 2014, Cancer Investigation CrossRef
36. Trial watch: Dendritic cell-based anticancer therapy
    Norma Bloy et al, 2014, OncoImmunology CrossRef
37. A New Hyaluronic Acid Derivative Obtained from Atom Transfer Radical Polymerization as a siRNA Vector for CD44 Receptor Tumor Targeting
    Fabio Salvatore Palumbo et al, 2015, Macromol. Biosci. CrossRef
38. 4-Acetylantroquinonol B inhibits colorectal cancer tumorigenesis and suppresses cancer stem-like phenotype
    Tung-Cheng Chang et al, 2015, Toxicology and Applied Pharmacology CrossRef
39. Sonic hedgehog-glioma associated oncogene homolog 1 signaling enhances drug resistance in CD44+/Musashi-1+ gastric cancer stem cells
    Min Xu et al, 2015, Cancer Letters CrossRef
40. Cancer stem cells in human digestive tract malignancies
    Fatemeh B. Rassouli et al, 2016, Tumor Biol. CrossRef
41. Advances and perspectives of colorectal cancer stem cell vaccine.
    Mei Guo et al, 0 CrossRef
42. Immunohistochemical expression of cancer stem cell related markers CD44 and CD133 in endometrial cancer
    Samah S. Elbasateeny et al, 2016, Pathology - Research and Practice CrossRef
43. Use of Cancer Stem Cells to Investigate the Pathogenesis of Colitis-associated Cancer
    Julie M. Davies et al, 2016, Inflammatory Bowel Diseases CrossRef
44. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
    Wen-Shin Song et al, 2016, J Chin Med Assoc CrossRef
45. AGR3 promotes the stemness of colorectal cancer via modulating Wnt/β-catenin signalling
    Jiangyang Chi et al, 2019, Cellular Signalling CrossRef
46. Genistein regulates tumor microenvironment and exhibits anticancer effect in dimethyl hydrazine-induced experimental colon carcinogenesis
    Vasudevan Sekar et al, 2016, BioFactors CrossRef
47. Identifying drug resistant cancer cells using microbubble well arrays
    Qihui Pu et al, 2017, Biomed Microdevices CrossRef
48. null
    Denis Corbeil et al, 2020 CrossRef
49. Triptolide inhibits CD133 + /CD44 + colon cancer stem cell growth and migration through triggering apoptosis and represses epithelial‐mesenchymal transition via downregulating expressions of snail, slug, and twist
    Eda Acikgoz et al, 2020, J Cell Biochem CrossRef
50. Organic Nanocarriers for Delivery and Targeting of Therapeutic Agents for Cancer Treatment
    Yang Peng et al, 2020, Adv. Therap. CrossRef
51. Significant decrease in the viability and tumor stem cell marker expression in tumor cell lines treated with curcumin
    Constanze Buhrmann et al, 2020, Journal of Herbal Medicine CrossRef
52. Radiotheranostic Targeting Cancer Stem Cells in Human Colorectal Cancer Xenografts
    Xianliang She et al, 2020, Mol Imaging Biol CrossRef
53. null
    Begum Dariya et al, 2020 CrossRef
54. The Capacity of High-Grade Serous Ovarian Cancer Cells to Form Multicellular Structures Spontaneously along Disease Progression Correlates with Their Orthotopic Tumorigenicity in Immunosuppressed Mice
    Alicia Goyeneche et al, 2020, Cancers CrossRef
55. Puerarin 6″‐O‐xyloside suppresses growth, self‐renewal and invasion of lung cancer stem‐like cells derived from A549 cells via regulating Akt/c‐Myc signalling
    Xiaomei Tao et al, 2020, Clin Exp Pharmacol Physiol CrossRef
56. Cancer stem cells (CSCs), cervical CSCs and targeted therapies
    Ruixia Huang et al, 2017, Oncotarget CrossRef
57. Anti-EGFR antibody sensitizes colorectal cancer stem-like cells to Fluorouracil-induced apoptosis by affecting autophagy
    Ye Feng et al, 2016, Oncotarget CrossRef
58. Different Camptothecin Sensitivities in Subpopulations of Colon Cancer Cells Correlate with Expression of Different Phospho-Isoforms of Topoisomerase I with Different Activities
    Cinzia Tesauro et al, 2020, Cancers CrossRef
59. Isolation and identification of tumor‑initiating cell properties in human gallbladder cancer cell lines using the marker cluster of differentiation 133
    Jiwei Yu et al, 2017, Oncol Lett CrossRef
60. Anti‑inflammatory drug resistance selects putative cancer stem cells in a cellular model for genetically predisposed colon cancer
    Nitin Telang, 2017, Oncol Lett CrossRef
61. In vitro characterization of spheres derived from colorectal cancer cell lines.
    Magdalena Szarynska, 0 CrossRef
62. Salvianolic acid B reverses multidrug resistance in nude mice bearing human colon cancer stem cells
    Piaoting Guo et al, 2018, Mol Med Report CrossRef
63. Phytol Down-Regulates Expression of Some Cancer Stem Cell Markers and Decreases Side Population Proportion in Human Embryonic Carcinoma NCCIT Cells
    Sara Soltanian et al, 2020, Nutrition and Cancer CrossRef
64. STAT3 Mediated miR-30a-5p Inhibition Enhances Proliferation and Inhibits Apoptosis in Colorectal Cancer Cells
    Chun-Chia Cheng et al, 2020, IJMS CrossRef
65. Enrichment of cancer-initiating cells from colon cancer cells through porous polymeric membranes by a membrane filtration method
    Tzu-Cheng Sung et al, 2020, J. Mater. Chem. B CrossRef
66. Cancer Stem-like Properties in Colorectal Cancer Cells with Low Proteasome Activity
    Koji Munakata et al, 2016, Clin Cancer Res CrossRef
67. Autocrine Secretion of Progastrin Promotes the Survival and Self-Renewal of Colon Cancer Stem–like Cells
    Julie Giraud et al, 2016, Cancer Res CrossRef
68. Circulating Tumor Cells Expressing Markers of Tumor-Initiating Cells Predict Poor Survival and Cancer Recurrence in Patients with Pancreatic Ductal Adenocarcinoma
    Katherine E. Poruk et al, 2017, Clin Cancer Res CrossRef
69. A nanotherapeutic strategy to overcome chemotherapeutic resistance of cancer stem-like cells
    Shiyang Shen et al, 2021, Nat. Nanotechnol. CrossRef
70. CD44 polymorphisms and its variants, as an inconsistent marker in cancer investigations
    Mohammad Mahmoudi Gomari et al, 2021, Mutation Research/Reviews in Mutation Research CrossRef
71. Significance of Kynurenine 3-Monooxygenase Expression in Colorectal Cancer
    Chun-Yu Liu et al, 2021, Front. Oncol. CrossRef
72. Cancer Stem Cell Marker CD44 Plays Multiple Key Roles in Human Cancers: Immune Suppression/Evasion, Drug Resistance, Epithelial–Mesenchymal Transition, and Metastasis
    Kevin Dzobo et al, 2021, OMICS: A Journal of Integrative Biology CrossRef
73. The Novel FAT4 Activator Jujuboside A Suppresses NSCLC Tumorigenesis by Activating HIPPO Signaling and Inhibiting YAP Nuclear Translocation
    Wensheng Wang et al, 2021, Pharmacological Research CrossRef
74. Isolation and Characterization of Chemo-Resistant Stem Cells from a Mouse Model of Hereditary Non-Polyposis Colon Cancer
    Nitin Telang, 2021, SCCAA CrossRef
75. The Tumorigenic Properties of EZH2 are Mediated by MiR-26a in Uveal Melanoma
    Yao Li et al, 2021, Front. Mol. Biosci. CrossRef
76. Novel drug delivery systems based on silver nanoparticles, hyaluronic acid, lipid nanoparticles and liposomes for cancer treatment
    Hanaa Ali Hussein et al, 2021, Appl Nanosci CrossRef
77. MicroRNA‑8063 targets heterogeneous nuclear ribonucleoprotein AB to inhibit the self‑renewal of colorectal cancer stem cells via the Wnt/β‑catenin pathway.
    Zheng-Quan Chen et al, 2021, Oncol Rep CrossRef
78. Cancer Stem Cell for Tumor Therapy
    Binjie Huang et al, 2021, Cancers CrossRef
79. Purification of Colon Carcinoma Cells from Primary Colon Tumor Using a Filtration Method via Porous Polymeric Filters
    Jia-Hua Wang et al, 2021, Polymers CrossRef
80. KLK6 mediates stemness and metabolism of gastric carcinoma cells via the PI3K/AKT/mTOR signaling pathway
    Dong Zhou et al, 2021, Oncol Lett CrossRef
81. Stemness, Inflammation and Epithelial–Mesenchymal Transition in Colorectal Carcinoma: The Intricate Network
    Inese Briede et al, 2021, IJMS CrossRef
82. Development of a Stable Peptide-Based PET Tracer for Detecting CD133-Expressing Cancer Cells
    Kuan Hu et al, 2021, ACS Omega CrossRef
83. Implication of Different Tumor Biomarkers in Drug Resistance and Invasiveness in Primary and Metastatic Colorectal Cancer Cell Lines
    Marta Sánchez-Díez et al, 2022, Biomedicines CrossRef
84. Extracts from lichen Lobaria retigera decrease the stemness potential of colorectal cancer cells
    Rui Zhou et al, 2022, mat express CrossRef
85. Transcription Factor PROX1 Suppresses Notch Pathway Activation via the Nucleosome Remodeling and Deacetylase Complex in Colorectal Cancer Stem-like Cells.
    Jenny Högström et al, 2018, Cancer Res CrossRef
86. Single-cell sequencing reveals CD133+CD44−-originating evolution and novel stemness related variants in human colorectal cancer
    Xiaoyan Zhang et al, 2022, eBioMedicine CrossRef
87. PI3K/Akt/mTOR Signaling Pathway in Cancer Stem Cells
    Mohsen Karami Fath et al, 2022, Pathology - Research and Practice CrossRef
88. Disulfiram increases the efficacy of 5-fluorouracil in organotypic cultures of colorectal carcinoma
    Michal Hendrych et al, 2022, Biomedicine & Pharmacotherapy CrossRef
89. Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer
    Priya Yadav et al, 2022, J Nanobiotechnol CrossRef
90. Dual‐Purpose 3D‐Silica Nanostructure Matrix for Rapid Epigenetic Reprogramming of Tumor Cell to Cancer Stem Cell Spheroid
    Anish Hiresha Verma et al, 2022, Small Methods CrossRef
91. Molecular Basis of Resveratrol-Induced Resensitization of Acquired Drug-Resistant Cancer Cells
    Chul Yung Choi et al, 2022, Nutrients CrossRef
92. Targeted Lymphoma Therapy Using a Gold Nanoframework-Based Drug Delivery System
    Manpreet Bariana et al, 2023, ACS Appl. Mater. Interfaces CrossRef
93. The role of hypoxia-inducible factors in breast cancer stem cell specification
    Mohsen Karami Fath et al, 2023, Pathology - Research and Practice CrossRef
94. Sohlh2 Regulates the Stemness and Differentiation of Colon Cancer Stem Cells by Downregulating LncRNA-H19 Transcription
    Ruihong Zhang et al, 2023 CrossRef
95. Inflammation-Related Signature Profile Expression as a Poor Prognosis Marker after Oxaliplatin Treatment in Colorectal Cancer
    Toni Martinez-Bernabe et al, 2023, IJMS CrossRef
96. Enhancing Anti-Tumorigenic Efficacy of Eugenol in Human Colon Cancer Cells Using Enzyme-Responsive Nanoparticles
    Nisitha Wijewantha et al, 2023, Cancers CrossRef
97. New Horizons in Metastatic Colorectal Cancer: Prognostic Role of CD44 Expression
    Pina Ziranu et al, 2023, Cancers CrossRef
98. Advancing biomarker development for diagnostics and therapeutics using solid tumour cancer stem cell models
    Samuel Sherng Young Wang, 2023, Tumori CrossRef
99. UBXN2A suppresses the Rictor-mTORC2 signaling pathway, an established tumorigenic pathway in human colorectal cancer
    Sanam Sane et al, 2023, Oncogene CrossRef
100. Differences and Similarities between Colorectal Cancer Cells and Colorectal Cancer Stem Cells: Molecular Insights and Implications
     Derya Erisik et al, 2023, ACS Omega CrossRef
101. Establishment of a tissue‐engineered colon cancer model for comparative analysis of cancer cell lines
     Iman Hassani et al, 2023, J Biomedical Materials Res CrossRef
102. Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting colorectal CSCs
     Qi Zhao et al, 2024, Exp Hematol Oncol CrossRef
103. Unleashing the Potential of Camptothecin: Exploring Innovative Strategies for Structural Modification and Therapeutic Advancements
     Zheng Chen et al, 2024, J. Med. Chem. CrossRef
104. GTP binding protein 2 maintains the quiescence, self-renewal, and chemoresistance of mouse colorectal cancer stem cells via promoting Wnt signaling activation
     Chao Ke et al, 2024, Heliyon CrossRef
105. Hyaluronan-based nano-formulation with mesoporous silica enhances the anticancer efficacy of phloroglucinol against gastrointestinal cancers
     Lakshmi Shanmugam et al, 2024, International Journal of Biological Macromolecules CrossRef
106. CD44 and CD133 protein expression might serve as a prognostic factor for early occurrence castration‐resistant prostate cancer
     Yayi Dwina et al, 2024, The Prostate CrossRef
107. Double‐Layered Hollow Mesoporous Cuprous Oxide Nanoparticles for Double Drug Sequential Therapy of Tumors
     Zongheng Li et al, 2024, Advanced Materials CrossRef
108. Sono-promoted piezocatalysis and low-dose drug penetration for personalized therapy via tumor organoids
     Zhiyi Gong et al, 2024, Journal of Colloid and Interface Science CrossRef
109. Cancer stem cells: advances in knowledge and implications for cancer therapy
     Xianjing Chu et al, 2024, Sig Transduct Target Ther CrossRef
110. LncRNA BASP1-AS1 is a positive regulator of stemness and pluripotency in human SH-SY5Y neuroblastoma cells
     Shubham Krishna et al, 2024, Biochemical and Biophysical Research Communications CrossRef
111. Intricate relationship between cancer stemness, metastasis, and drug resistance.
     Tikam Chand Dakal et al, 2024, MedComm (2020) CrossRef
112. Effective Targeting of Colorectal Cancer Stem Cells by Inducing Differentiation Mediated by Low‐Dose Vitamin C via β‐Catenin Retention in the Cell Membrane
     Shanooja Shanavas et al, 2024, J of Cellular Biochemistry CrossRef
113. A Newly Synthesized Benzimidazolium Salt: 1‐(2‐Cyanobenzyl)‐3‐(4‐Vinylbenzyl)‐1H‐Benzo[D]imidazol‐3‐ium Chloride as a Potential Anticancer Agent for Colon Cancer Treatment, In Vitro Study
     Nazmiye Bitgen et al, 2025, J Biochem & Molecular Tox CrossRef
114. Cascade specific endogenous Fe3+ interference and in situ catalysis for tumor therapy with stemness suppression
     Jiajie Chen et al, 2025 CrossRef
115. Cisplatin-eugenol Pt(IV) prodrugs target colon cancer stem cells: A novel strategy for enhanced anticancer efficacy
     Vojtech Novohradsky et al, 2025, Biomedicine & Pharmacotherapy CrossRef